Humacyte (HUMA) Net Cash Flow (2020 - 2026)
Humacyte (HUMA) posted quarterly Net Cash Flow of -$2.0 million for Q1 2026, down 110.91% year-over-year from $17.9 million in Q1 2025, and down 106.29% quarter-over-quarter from $31.1 million in Q4 2025.
Humacyte (HUMA) Net Cash Flow (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Net Cash Flow for 7 consecutive years, with -$2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow fell 110.91% year-over-year to -$2.0 million; the TTM figure through Mar 2026 stood at -$64.3 million (down 2338.82% YoY), while the FY2025 annual figure was -$44.4 million, down 405.96% from the prior year.
- Net Cash Flow declined to -$2.0 million in Q1 2026 per HUMA's latest filing, from $31.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $35.1 million in Q1 2024 and bottomed at -$68.5 million in Q3 2025.
- Historically, Net Cash Flow has averaged -$9.9 million across 5 years, with a median of -$17.2 million in 2022.
- Annual changes were most pronounced in 2022 — Net Cash Flow plunged 506.64% — and 2024, when it jumped 273.53%.
- Humacyte's Net Cash Flow stood at -$13.9 million in 2022, then tumbled by 40.23% to -$19.5 million in 2023, then jumped by 224.85% to $24.4 million in 2024, then advanced by 27.32% to $31.1 million in 2025, then sank by 106.29% to -$2.0 million in 2026.
- Business Quant data shows HUMA's Net Cash Flow at -$2.0 million in Q1 2026, $31.1 million in Q4 2025, and -$68.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.81 Bn | 131.96 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 86.33 Bn | 78.34 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 65.13 Bn | 59.95 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.47 Bn | 55.33 Bn | 52.00 Mn | -183.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 407.41 Mn |
| 6 | Alnylam Pharmaceuticals | 31.04 Bn | 27.73 Bn | 992.69 Mn | -496,000.00 |
| 7 | BioNTech SE | 28.48 Bn | 10.09 Bn | 668.28 Mn | -2.83 Bn |
| 8 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | -37.14 Mn |
| 9 | Royalty Pharma | 27.23 Bn | 26.39 Bn | - | 225.59 Mn |
| 10 | Humacyte | 156.43 Mn | 156.43 Mn | -825,000.00 | 31.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 31.33 Mn |
| Jun 30, 2026 | 31.33 Mn |
| Mar 31, 2026 | -1.95 Mn |
| Mar 31, 2026 | -1.95 Mn |
| Dec 31, 2025 | 31.05 Mn |
| Dec 31, 2025 | 31.05 Mn |
| Sep 30, 2025 | -68.54 Mn |
| Sep 30, 2025 | -68.54 Mn |
| Jun 30, 2025 | -24.82 Mn |
| Jun 30, 2025 | -24.82 Mn |
| Mar 31, 2025 | 17.91 Mn |
| Mar 31, 2025 | 17.91 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Dec 31, 2024 | 24.39 Mn |
| Sep 30, 2024 | -22.99 Mn |
| Sep 30, 2024 | -22.99 Mn |
| Jun 30, 2024 | -21.94 Mn |
| Jun 30, 2024 | -21.94 Mn |
| Mar 31, 2024 | 35.06 Mn |
| Mar 31, 2024 | 35.06 Mn |